Cilostazol: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Cilostazol. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Headache | 34% |
| Diarrhea | 19% |
| Abnormal stools | 15% |
| Infection | 14% |
| Rhinitis | 12% |
| Palpitation | 10% |
| Dizziness | 10% |
| Pharyngitis | 10% |
| Peripheral edema | 9% |
| Back pain | 7% |
| Nausea | 7% |
| Dyspepsia | 6% |
| Abdominal pain | 5% |
| Tachycardia | 4% |
| Cough increased | 4% |
| Flatulence | 3% |
| Myalgia | 3% |
| Vertigo | 3% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Cilostazol Tablets, USP are indicated for the reduction of symptoms of intermittent claudication, as indicated by an increased walking distance.
Source: FDA labeling via NIH DailyMed (set 151d1497…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.